A pharmacovigilance study of FDA adverse events for sugammadex
A pharmacovigilance study of FDA adverse events for sugammadex
About this item
Full title
Author / Creator
Mao, Xiaoyan , Zhang, Rong , Liang, Xia , Liu, Fan , Dai, Yuan , Wang, Meng , Huang, Haoquan and Fu, Ganglan
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
AbstractBackgroundSugammadex, a selective steroidal neuromuscular blocking agent reversal agent, is increasingly employed for the rapid restoration of neuromuscular function. This study aimed to conduct a comprehensive evaluation of sugammadex's safety profile. MethodsAdverse events (AEs) related to sugammadex reported in the FDA Adverse Event Repo...
Alternative Titles
Full title
A pharmacovigilance study of FDA adverse events for sugammadex
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3069172787
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3069172787
Other Identifiers
ISSN
0952-8180,1873-4529
E-ISSN
1873-4529
DOI
10.1016/j.jclinane.2024.111509
